Search

Search Constraints

You searched for: Author/Creator Speer, Claudius

Search Results

1. 7 Modified immune cell therapy ameliorates murine lupus nephritis and induces regulatory cell subsets. (April 2019)

2. Cell Cycle Biomarkers and Soluble Urokinase-Type Plasminogen Activator Receptor for the Prediction of Sepsis-Induced Acute Kidney Injury Requiring Renal Replacement Therapy: A Prospective, Exploratory Study. Issue 12 (December 2019)

3. Cyclophosphamide induction dose and outcomes in ANCA-associated vasculitis with renal involvement: A comparative cohort study. Issue 29 (23rd July 2021)

4. Early Humoral Responses of Hemodialysis Patients after COVID-19 Vaccination with BNT162b2. Issue 7 (July 2021)

5. Effectiveness of different immunoadsorption columns for anti-A/B antibody depletion. (December 2019)

6. FC 043SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) DETERMINES OUTCOMES IN CLINICAL AND EXPERIMENTAL SEPTIC ACUTE KIDNEY INJURY. (29th May 2021)

7. FP190MODIFIED IMMUNE CELL THERAPY AMELIORATES MURINE LUPUS NEPHRITIS AND INDUCES REGULATORY CELL SUBSETS. (13th June 2019)

8. Immune Response to COVID-19 mRNA Vaccination in Previous Nonresponder Kidney Transplant Recipients After Short-term Withdrawal of Mycophenolic Acid 1 and 3 Months After an Additional Vaccine Dose. Issue 5 (9th January 2023)

9. Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial. Issue 11 (11th November 2022)

10. Induction of Long-Lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant Recipients. Issue 1 (22nd January 2023)